SIRT7-dependent deacetylation of the U3-55k protein controls pre-rRNA processing

Nature Communications

Volumn 7, Issue , 2016, Pages

  Chen, Sifan ^a   Blank, Maximilian Felix ^a   Iyer, Aishwarya ^a   Huang, Bingding ^b,c   Wang, Lin ^b   Grummt, Ingrid ^a   Voit, Renate ^a  

^a GERMAN CANCER RESEARCH CENTER   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c NEO New Oncology GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PRE RIBOSOMAL RNA; PROTEIN; RIBOSOME RNA; RNA 18S; SIRTUIN 7; SMALL NUCLEOLAR RNA; U3 55K PROTEIN; UNCLASSIFIED DRUG; RIBONUCLEOPROTEIN, U3 SMALL NUCLEOLAR; RNA PRECURSOR; SIRT7 PROTEIN, HUMAN; SIRTUIN; SMALL NUCLEOLAR RIBONUCLEOPROTEIN;

CELLS AND CELL COMPONENTS; CYTOGENETICS; ENZYME; ENZYME ACTIVITY; PROTEIN; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOGENESIS; CELL METABOLISM; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DEACETYLATION; FLUORESCENCE MICROSCOPY; GEL ELECTROPHORESIS; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; L1210 CELL LINE; NONHUMAN; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN ACETYLATION; PROTEIN DEPLETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PROCESSING; U2OS CELL LINE; FLUORESCENT ANTIBODY TECHNIQUE; GENE INACTIVATION; GENE SILENCING; GENETICS; HEK293 CELL LINE; METABOLISM; NORTHERN BLOTTING; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; FLUORESCENT ANTIBODY TECHNIQUE; GENE KNOCKDOWN TECHNIQUES; GENE KNOCKOUT TECHNIQUES; HEK293 CELLS; HUMANS; IMMUNOPRECIPITATION; IN VITRO TECHNIQUES; RIBONUCLEOPROTEINS, SMALL NUCLEOLAR; RNA PRECURSORS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, RIBOSOMAL, 18S; RNA, SMALL NUCLEOLAR; SIRTUINS;

EID: 84957998650     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10734     Document Type: Article

References (51)

1. Henras, A. K. et al. The post-transcriptional steps of eukaryotic ribosome biogenesis. Cell. Mol. Life Sci. 65, 2334-2359 (2008).
2. Tafforeau, L. et al. The complexity of human ribosome biogenesis revealed by systematic nucleolar screening of Pre-rRNA processing factors. Mol. Cell 51, 539-551 (2013).
3. Lafontaine, D. L. J. Noncoding RNAs in eukaryotic ribosome biogenesis and function. Nat. Struct. Mol. Biol. 22, 11-19 (2015).
4. Watkins, N. J. & Bohnsack, M. T. The box C/D and H/ACA snoRNPs: key players in the modification, processing, and the dynamic folding of ribosomal RNA. Wiley Interdiscip. Rev. RNA 3, 397-414 (2012).
5. Kass, S., Tyc, K., Steitz, J. A. & Sollner-Webb, B. The U3 small nucleolar ribonucleoprotein functions in the first step of preribosomal RNA processing. Cell 60, 897-908 (1990).
6. Lübben, B., Marshallsay, C., Rottmann, N. & Lührmann, R. Isolation of U3 snoRNP from CHO cells: a novel 55 kDa protein binds to the central part of U3 snoRNA. Nucleic Acids Res. 21, 5377-5385 (1993).
7. Dragon, F. et al. A large nucleolar U3 ribonucleoprotein required for 18S ribosomal RNA biogenesis. Nature 417, 967-970 (2002).
8. Gallagher, J. E. et al. RNA polymerase I transcription and pre-rRNA processing are linked by specific SSU processome components. Genes Dev. 18, 2506-2517 (2004).
9. Granneman, S. & Baserga, S. J. Crosstalk in gene expression: coupling and co-regulation of rDNA transcription, pre-ribosome assembly and pre-rRNA processing. Curr. Opin. Cell Biol. 17, 281-286 (2005).
10. Sloan, K. E., Bohnsack, M. T., Schneider, C. & Watkins, N. J. The roles of SSU processome components and surveillance factors in the initial processing of human ribosomal RNA. RNA 20, 540-550 (2014).
11. Phipps, K. R., Charette, J. M. & Baserga, S. J. The small subunit processome in ribosome biogenesis - progress and prospects. Wiley Interdiscip. Rev. RNA 2, 1-21 (2011).
12. Beltrame, M. & Tollervey, D. Identification and functional analysis of two U3 binding sites on yeast pre-ribosomal RNA. EMBO J. 11, 1531-1542 (1992).
13. Borovjagin, A. V. & Gerbi, S. A. The spacing between functional Cis-elements of U3 snoRNA is critical for rRNA processing. J. Mol. Biol. 300, 57-74 (2000).
14. Dutca, L. M., Gallagher, J. E. & Baserga, S. J. The initial U3 snoRNA:pre-rRNA base pairing interaction required for pre-18S rRNA folding revealed by in vivo chemical probing. Nucleic Acids Res. 39, 5164-5180 (2011).
15. Kudla, G., Granneman, S., Hahn, D., Beggs, J. D. & Tollervey, D. Cross-linking, ligation, and sequencing of hybrids reveals RNA-RNA interactions in yeast. Proc. Natl Acad. Sci. USA 108, 10010-10015 (2011).
16. Mullineux, S. T. & Lafontaine, D. L. Mapping of cleavage sites on mammalian pre-rRNAs: where do we stand? Biochimie 94, 1521-1532 (2012).
17. Hughes, J. M. & Ares, Jr M. Depletion of U3 small nucleolar RNA inhibits cleavage in the 5′ external transcribed spacer of yeast pre-ribosomal RNA and impairs formation of 18S ribosomal RNA. EMBO J. 10, 4231-4239 (1991).
18. Haigis, M. C. & Sinclair, D. A. Mammalian sirtuins: biological insights and disease relevance. Annu. Rev. Pathol. 5, 253-295 (2010).
19. Houtkooper, R. H., Pirinen, E. & Auwerx, J. Sirtuins as regulators of metabolism and healthspan. Nat. Rev. Mol. Cell Biol. 13, 225-238 (2012).
20. Chang, H. C. & Guarente, L. SIRT1 and other sirtuins in metabolism. Trends Endocrinol. Metab. 25, 138-145 (2014).
21. +: an old metabolite controlling new metabolic signaling pathways. Endocr. Rev. 31, 194-223 (2010).
22. Imai, S. & Guarente, L. Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases. Trends Pharmacol. Sci. 31, 212-220 (2010).
23. Grob, A. et al. Involvement of SIRT7 in resumption of rDNA transcription at the exit from mitosis. J. Cell Sci. 122, 489-498 (2009).
24. Chen, S. et al. Repression of RNA polymerase I upon stress is caused by inhibition of RNA-dependent deacetylation of PAF53 by SIRT7. Mol. Cell 52, 303-313 (2013).
25. Ford, E. et al. Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev. 20, 1075-1080 (2006).
26. Ashraf, N. et al. Altered sirtuin expression is associated with node-positive breast cancer. Br. J. Cancer 95, 1056-1061 (2006).
27. Geng, Q., Peng, H., Chen, F., Luo, R. & Li, R. High expression of Sirt7 served as a predictor of adverse outcome in breast cancer. Int. J. Clin. Exp. Pathol. 8, 1938-1945 (2015).
28. Zhang, S. et al. Sirt7 promotes gastric cancer growth and inhibits apoptosis by epigenetically inhibiting miR-34a. Sci. Rep. 5, 9787 (2015).
29. Prieto, J. L. & McStay, B. Recruitment of factors linking transcription and processing of pre-rRNA to NOR chromatin is UBF-dependent and occurs independent of transcription in human cells. Genes Dev. 21, 2041-2054 (2007).
30. Kos, M. & Tollervey, D. Yeast pre-rRNA processing and modification occur cotranscriptionally. Mol. Cell 37, 809-820 (2010).
31. Choudhary, C. et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-840 (2009).
32. Watkins, N. J. et al. Assembly and maturation of the U3 snoRNP in the nucleoplasm in a large dynamic multiprotein complex. Mol. Cell 16, 789-798 (2004).
33. Shultz, A., Nottrott, S., Watkins, N. J. & Lührmann, R. Protein-protein and protein-RNA contacts both contribute to the 15.5k-mediated assembly of the U4/U6 snRNP and the box C/D snoRNPs. Mol. Cell. Biol. 26, 5146-5154 (2006).
34. Granneman, S. et al. The hU3-55k protein requires 15.5k binding to the box B/C motif as well as flanking RNA elements for its association with the U3 small nucleolar RNA in vitro. J. Biol. Chem. 277, 48490-48500 (2002).
35. Zhang, L., Lin, J. & Ye, K. Structural and functional analysis of the U3 snoRNA binding protein Rrp9. RNA 19, 701-711 (2013).
36. Barber, M. F. et al. SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature 487, 114-118 (2012).
37. Paredes, S., Villanova, L. & Chua, K. F. Molecular pathways: emerging roles of mammalian Sirtuin SIRT7 in cancer. Clin. Cancer Res. 20, 1741-1746 (2014).
38. Yu, H. et al. Overexpression of sirt7 exhibits oncogenic property and serves as a prognostic factor in colorectal cancer. Clin. Cancer Res. 20, 3434-3445 (2014).
39. Malik, S. et al. SIRT7 inactivation reverses metastatic phenotypes in epithelial and mesenchymal tumors. Sci. Rep. 5, 9841 (2015).
40. Tsai, Y. C., Greco, T. M. & Cristea, I. M. Sirtuin 7 plays a role in ribosome biogenesis and protein synthesis. Mol. Cell. Proteomics 13, 73-83 (2014).
41. Ryu, D. et al. A SIRT7-dependent acetylation switch of GABPβ1 controls mitochondrial function. Cell Metab. 20, 856-869 (2014).
42. Grandi, P. et al. 90S pre-ribosomes include the 35S pre-rRNA, the U3 snoRNP, and the 40S subunit processing factors but predominantly lack 60S synthesis factors. Mol. Cell 10, 105-115 (2002).
43. Knox, A. A. et al. A weak C' box renders U3 snoRNA levels dependent on hU3-55k binding. Mol. Cell. Biol. 31, 2404-2412 (2011).
44. Kent, T., Lapik, Y. R. & Pestov, D. G. The 5′ external transcribed spacer in mouse ribosomal RNA contains two cleavage sites. RNA 15, 14-20 (2009).
45. Shin, J. et al. SIRT7 represses Myc activity to suppress ER stress and prevent fatty liver disease. Cell Rep. 5, 654-665 (2013).
46. Hubbi, M. E., Hu, H., Kshitiz, Gilkes, D. M. & Semenza, G. L. Sirtuin-7 inhibits the activity of hypoxia-inducible factors. J. Biol. Chem. 288, 20768-20775 (2013).
47. Kiran, S., Oddi, V. & Ramakrishna, G. Sirtuin 7 promotes cellular survival following genomic stress by attenuation of DNA damage, SAPK activation and p53 response. Exp. Cell Res. 331, 123-141 (2015).
48. Muth, V., Nadaud, S., Grummt, I. & Voit, R. Acetylation of TAF(I)68, a subunit of TIF-IB/SL1, activates RNA polymerase I transcription. EMBO J. 20, 1353-1362 (2001).
49. Wang, T., Wei, J. J., Sabatini, D. M. & Lander, E. S. Genetic screens in human cells using the CRISPR-Cas9 system. Science 343, 80-84 (2014).
50. Shalem, O. et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343, 84-87 (2014).
51. Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783-784 (2014).